42 reports of this reaction
3.9% of all POTASSIUM NITRATE, SODIUM FLUORIDE reports
#7 most reported adverse reaction
THERAPEUTIC PRODUCT EFFECT INCOMPLETE is the #7 most commonly reported adverse reaction for POTASSIUM NITRATE, SODIUM FLUORIDE, manufactured by Haleon US Holdings LLC. There are 42 FDA adverse event reports linking POTASSIUM NITRATE, SODIUM FLUORIDE to THERAPEUTIC PRODUCT EFFECT INCOMPLETE. This represents approximately 3.9% of all 1,087 adverse event reports for this drug.
Patients taking POTASSIUM NITRATE, SODIUM FLUORIDE who experience therapeutic product effect incomplete should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
THERAPEUTIC PRODUCT EFFECT INCOMPLETE is moderately reported among POTASSIUM NITRATE, SODIUM FLUORIDE users, representing a notable but not dominant share of adverse events.
In addition to therapeutic product effect incomplete, the following adverse reactions have been reported for POTASSIUM NITRATE, SODIUM FLUORIDE:
The following drugs have also been linked to therapeutic product effect incomplete in FDA adverse event reports:
THERAPEUTIC PRODUCT EFFECT INCOMPLETE has been reported as an adverse event in 42 FDA reports for POTASSIUM NITRATE, SODIUM FLUORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
THERAPEUTIC PRODUCT EFFECT INCOMPLETE accounts for approximately 3.9% of all adverse event reports for POTASSIUM NITRATE, SODIUM FLUORIDE, making it a notable side effect.
If you experience therapeutic product effect incomplete while taking POTASSIUM NITRATE, SODIUM FLUORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.